By David Vergun, DOD News

U.S. Army researchers are working to rapidly develop and test experimental vaccines to combat COVID-19, Army Secretary Ryan D. McCarthy said.

The Army is also collaborating with the private sector and other government entities on 24 vaccine candidates, some of which are headed for human testing after having been tested on animals, McCarthy told reporters at a recent Pentagon news conference.

If history is any indicator of future success, there is reason to be hopeful. After all, being at the forefront of medical breakthroughs is nothing new for Army researchers.

Fighting Malaria

Due to their ability to carry and spread diseases such as malaria, mosquitoes are one of the deadliest insects in the world, killing an average of 725,000 people a year, said Army Col. And Dr. Deydre Teyhen, commander of the Walter Reed Army Institute of Research. That surpasses the combined annual number of U.S. deaths from combat (475,000), deadly snakebites (50,000), crocodile attacks (1,000) and shark attacks (10).

A mosquito. | Photo credit U.S. Navy/DVIDS

To reduce deaths caused by mosquitoes, Walter Reed Army Institute of Research has acted on several fronts, Teyhen said, by providing proactive medical diplomacy, delivering vaccines and vector control and leading the world in malaria drug and vaccine development.

Fighting Multidrug-Resistant Infections

An antibiotic drug developed by Army researchers several years ago is now available to treat service members who have life-threatening, multidrug-resistant (or, MDR) bacterial infections.

Arbekacin is a new antibiotic treatment for MDR infections. Those types of infections may complicate wounds suffered by soldiers in combat, said Army Col. and Dr. Michael Zapor, an infectious diseases physician at Walter Reed National Military Medical Center in Bethesda, Maryland.

“Of all the bacterial species found on the planet, relatively few are intrinsically multidrug-resistant pathogens,” Zapor said. “In Iraq and Afghanistan, the bacterium known as ‘acinetobacter’ is one such MDR bacterium that has caused problems in our patient population.”

Photo credit U.S. Army

Army Col. Dr. Michael Zapor, a staph infectious diseases physician at Walter Reed National Military Medical Center, treats local citizens during his 2010 tour in Afghanistan as a battalion surgeon with the 82nd Airborne Division.

Acinetobacter is commonly found in the water and soil of regions such as Iraq and Afghanistan, Zapor said. Although it’s intrinsically resistant to many antibiotics, it’s not especially virulent and generally not problematic in humans unless their immune system has been severely compromised or the bacterium is inoculated deep into macerated tissue, as would occur with massive open wounds resulting from battle injuries.

Infections caused by the bacterium were prevalent during the Vietnam War, he said. But at the time, antibiotics were usually successful in eradicating acinetobacter infections. However, over time, resistance emerged, and antibiotics became less effective against many pathogenic bacteria, including acinetobacter.

Fighting Yellow Fever

A lot of service members were taken out of the fight in 1898 during the Spanish-American War due to yellow fever.

Photo credit U.S. Army

A formal portrait of Army Maj. (Dr.) Walter Reed.

The Army created the Yellow Fever Commission, led by Army Maj. and Dr. Walter Reed, which determined that mosquitoes were the carriers of the disease. The commission developed effective control programs to eradicate the mosquitoes.

Fighting Adenovirus

Acute respiratory diseases were fairly common among service members in the early 1950s. Maurice Hilleman, a microbiologist with the Army Medical Center’s Department of Respiratory Diseases, discovered that the adenovirus was the culprit.

Walter Reed Army Institute of Research created an adenovirus vaccine in 1956, just three years after its discovery.

-This story originally appeared on It has been edited for